000 01463 a2200433 4500
005 20250516021724.0
264 0 _c20110419
008 201104s 0 0 eng d
022 _a1755-8794
024 7 _a10.1186/1755-8794-4-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLoboda, Andre
245 0 0 _aEMT is the dominant program in human colon cancer.
_h[electronic resource]
260 _bBMC medical genomics
_cJan 2011
300 _a9 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aCell Line, Tumor
650 0 4 _aColonic Neoplasms
_xmetabolism
650 0 4 _aDisease Progression
650 0 4 _aEpithelial-Mesenchymal Transition
650 0 4 _aGene Expression Profiling
_xmethods
650 0 4 _aHumans
650 0 4 _aPrincipal Component Analysis
650 0 4 _aRecurrence
650 0 4 _aVimentin
_xmetabolism
700 1 _aNebozhyn, Michael V
700 1 _aWatters, James W
700 1 _aBuser, Carolyne A
700 1 _aShaw, Peter Martin
700 1 _aHuang, Pearl S
700 1 _aVan't Veer, Laura
700 1 _aTollenaar, Rob A E M
700 1 _aJackson, David B
700 1 _aAgrawal, Deepak
700 1 _aDai, Hongyue
700 1 _aYeatman, Timothy J
773 0 _tBMC medical genomics
_gvol. 4
_gp. 9
856 4 0 _uhttps://doi.org/10.1186/1755-8794-4-9
_zAvailable from publisher's website
999 _c20532692
_d20532692